Change template to: full
Review articles
Long-term survival with CML with imatinib or transplantation as first-line treatment: Comparison of outcomes from CML Studies IIIA and IV
Rüdiger Hehlmann
Stem cell transplantation for myeloproliferative diseases in the era of molecular therapy
Axel R. Zander
Opportunistic microflora at unusual sites: marker pathogens in severe posttransplant immune deficiency
Alexey B. Chukhlovin1, Olga S. Pankratova2